Imao T et al. |
Risk factors for malignancy in Japanese renal transplant recipients. |
2007 |
Cancer |
pmid:17407138
|
Jonas S et al. |
De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. |
1997 |
Cancer |
pmid:9305716
|
Gupta A et al. |
Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecan. |
2006 |
Cancer Chemother. Pharmacol. |
pmid:16404634
|
Naito M et al. |
Reversal of multidrug resistance by an immunosuppressive agent FK-506. |
1992 |
Cancer Chemother. Pharmacol. |
pmid:1370765
|
Holmes JA and Twentyman PR |
The activity of deoxyspergualin in multidrug-resistant cells. |
1995 |
Cancer Chemother. Pharmacol. |
pmid:7554042
|
Yamashita T et al. |
Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation. |
2016 |
Cancer Chemother. Pharmacol. |
pmid:27217047
|
Pawarode A et al. |
Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins. |
2007 |
Cancer Chemother. Pharmacol. |
pmid:17031644
|
Song W et al. |
Cancer gene therapy with iCaspase-9 transcriptionally targeted to tumor endothelial cells. |
2008 |
Cancer Gene Ther. |
pmid:18566614
|
Yoshizawa K et al. |
Establishment of Epstein-Barr virus-associated lymphoma cell line SUBL with t(2;3)(p11;q27) from a liver transplant patient. |
1993 |
Cancer Genet. Cytogenet. |
pmid:7506636
|
Hodi FS et al. |
Withdrawal of immunosuppression contributing to the remission of malignant melanoma: a case report. |
2005 |
Cancer Immun. |
pmid:15901138
|
Yamamoto S et al. |
Inhibition of anthralin-caused skin tumor promotion and interleukin-1 alpha production by potent immunosuppressant FK506. |
1994 |
Cancer Lett. |
pmid:7520353
|
Datta D et al. |
Calcineurin inhibitors activate the proto-oncogene Ras and promote protumorigenic signals in renal cancer cells. |
2009 |
Cancer Res. |
pmid:19903851
|
Matsumoto K et al. |
mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells. |
2009 |
Cancer Res. |
pmid:19738050
|
Krishnamurthy S et al. |
Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. |
2010 |
Cancer Res. |
pmid:21098716
|
Paulmurugan R et al. |
Molecular imaging of drug-modulated protein-protein interactions in living subjects. |
2004 |
Cancer Res. |
pmid:15026351
|
Dilling MB et al. |
Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor. |
1994 |
Cancer Res. |
pmid:7508822
|
Scheffold C et al. |
Visualization of effective tumor targeting by CD8+ natural killer T cells redirected with bispecific antibody F(ab')(2)HER2xCD3. |
2002 |
Cancer Res. |
pmid:12384539
|
Wandel C et al. |
P-glycoprotein and cytochrome P-450 3A inhibition: dissociation of inhibitory potencies. |
1999 |
Cancer Res. |
pmid:10463589
|
Aikawa Y et al. |
Essential role of PU.1 in maintenance of mixed lineage leukemia-associated leukemic stem cells. |
2015 |
Cancer Sci. |
pmid:25529853
|
Spain L et al. |
Management of toxicities of immune checkpoint inhibitors. |
2016 |
Cancer Treat. Rev. |
pmid:26874776
|
Radu CD et al. |
Cotton-made cellulose support for anti-allergic pajamas. |
2013 |
Carbohydr Polym |
pmid:23618296
|
Jiang H et al. |
Anti-tumor-promoting action of FK506, a potent immunosuppressive agent. |
1993 |
Carcinogenesis |
pmid:7678785
|
Hunt SA |
New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus. |
2000 May-Jun |
Cardiol Rev |
pmid:11174892
|
Ekman-Joelsson BM et al. |
Post-transplant lymphoproliferative disease is associated with early sternotomy and left ventricular hypoplasia during infancy: a population-based retrospective review. |
2017 |
Cardiol Young |
pmid:28780922
|
Schrepfer S et al. |
Inhibition of restenosis development after mechanical injury: a new field of application for malononitrilamides? |
2007 |
Cardiology |
pmid:17028423
|
Minamino T et al. |
Chronic treatment with FK506 increases p70 S6 kinase activity associated with reduced nitric oxide synthase activity in rabbit hearts. |
2000 |
Cardiovasc Drugs Ther |
pmid:10935155
|
Cai Q et al. |
Reduction of infarct size in isolated rat heart by CsA and FK506: possible role of phosphatase inhibition. |
1998 |
Cardiovasc Drugs Ther |
pmid:9926283
|
Seino Y et al. |
Multicenter prospective investigation on cardiovascular adverse effects of tacrolimus in kidney transplantations. |
2003 |
Cardiovasc Drugs Ther |
pmid:12975596
|
Radeleff B et al. |
Restenosis of the CYPHER-Select, TAXUS-Express, and Polyzene-F nanocoated cobalt-chromium stents in the minipig coronary artery model. |
2008 Sep-Oct |
Cardiovasc Intervent Radiol |
pmid:18095019
|
Waksman R et al. |
Efficacy and safety of pimecrolimus-eluting stents in porcine coronary arteries. |
2007 Oct-Dec |
Cardiovasc Revasc Med |
pmid:18053948
|
Bogossian H et al. |
Expression of NO Synthase Under Medication with Cyclosporine A, Mycophenolate Mofetil, and Tacrolimus during Development of Transplant Vasculopathy on Rat Cardiac Allograft. |
2016 |
Cardiovasc Ther |
pmid:26924260
|
Rezai N et al. |
Effects of granulocyte-colony stimulating factor on bone marrow-derived progenitor cells in murine cardiac transplantation. |
2010 Jan-Feb |
Cardiovasc. Pathol. |
pmid:19144547
|
Gajjar NA et al. |
FK506 vs. cyclosporin. Pathologic findings in 1067 endomyocardial biopsies. |
2003 Mar-Apr |
Cardiovasc. Pathol. |
pmid:12684161
|
Nakayama Y et al. |
Fabrication of drug-eluting covered stents with micropores and differential coating of heparin and FK506. |
2003 Apr-Jun |
Cardiovasc. Radiat. Med. |
pmid:14581087
|
Giordano A et al. |
FK506 can activate transforming growth factor-beta signalling in vascular smooth muscle cells and promote proliferation. |
2008 |
Cardiovasc. Res. |
pmid:18349138
|
Obayashi M et al. |
Spontaneous diastolic contractions and phosphorylation of the cardiac ryanodine receptor at serine-2808 in congestive heart failure in rat. |
2006 |
Cardiovasc. Res. |
pmid:16112660
|
Yamamoto K et al. |
Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart. |
2002 |
Cardiovasc. Res. |
pmid:12062710
|
Fauconnier J et al. |
Ca2+-dependent reduction of IK1 in rat ventricular cells: a novel paradigm for arrhythmia in heart failure? |
2005 |
Cardiovasc. Res. |
pmid:16083867
|
Zhang W |
Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy. |
2002 |
Cardiovasc. Res. |
pmid:11827679
|
Zhao YT et al. |
Sensitized signalling between L-type Ca2+ channels and ryanodine receptors in the absence or inhibition of FKBP12.6 in cardiomyocytes. |
2017 |
Cardiovasc. Res. |
pmid:28077437
|
Weinbrenner C et al. |
Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia. |
1998 |
Cardiovasc. Res. |
pmid:9747435
|
Wu Y and Anderson ME |
Reduced repolarization reserve in ventricular myocytes from female mice. |
2002 |
Cardiovasc. Res. |
pmid:11861046
|
Ono K et al. |
Altered interaction of FKBP12.6 with ryanodine receptor as a cause of abnormal Ca(2+) release in heart failure. |
2000 |
Cardiovasc. Res. |
pmid:11054478
|
Ono M et al. |
Dissociation of calmodulin from cardiac ryanodine receptor causes aberrant Ca(2+) release in heart failure. |
2010 |
Cardiovasc. Res. |
pmid:20388639
|
Barilli A et al. |
In human endothelial cells rapamycin causes mTORC2 inhibition and impairs cell viability and function. |
2008 |
Cardiovasc. Res. |
pmid:18250144
|
Bueno OF et al. |
Calcineurin and hypertrophic heart disease: novel insights and remaining questions. |
2002 |
Cardiovasc. Res. |
pmid:11922891
|
Feng X et al. |
Protective effect of FK506 on myocardial ischemia/reperfusion injury by suppression of CaN and ASK1 signaling circuitry. |
2011 |
Cardiovasc. Toxicol. |
pmid:21076890
|
Matl I |
[Newer immunosuppressive agents and their place in current practice]. |
2000 |
Cas. Lek. Cesk. |
pmid:22666925
|
Jung JH et al. |
Systemic immunosuppressive therapy inhibits in-stent restenosis in patients with renal allograft. |
2006 |
Catheter Cardiovasc Interv |
pmid:16969853
|
Berg R et al. |
Pimecrolimus and dual pimecrolimus-paclitaxel eluting stents decrease neointimal proliferation in a porcine model. |
2007 |
Catheter Cardiovasc Interv |
pmid:17932889
|
Wieneke H et al. |
Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits. |
2003 |
Catheter Cardiovasc Interv |
pmid:14571494
|
Schwartz RS |
Beauty's only skin deep: surface technologies emerge in stenting. |
2003 |
Catheter Cardiovasc Interv |
pmid:14571495
|
Ikeno F et al. |
Novel percutaneous adventitial drug delivery system for regional vascular treatment. |
2004 |
Catheter Cardiovasc Interv |
pmid:15390346
|
Hehrlein C |
Dual drug release from stents-will we be happy with thing one and thing two? |
2007 |
Catheter Cardiovasc Interv |
pmid:18022914
|
Kollum M et al. |
Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis. |
2005 |
Catheter Cardiovasc Interv |
pmid:15619311
|
Tamburino C et al. |
Real world safety and efficacy of the Janus Tacrolimus-Eluting stent: long-term clinical outcome and angiographic findings from the Tacrolimus-Eluting STent (TEST) registry. |
2009 |
Catheter Cardiovasc Interv |
pmid:19156896
|
Kornowski R |
A critical appraisal of the Janus carbostent. |
2009 |
Catheter Cardiovasc Interv |
pmid:19156897
|
Klein AJ and Brilakis ES |
Less may be more: insights on dual antiplatelet therapy duration after drug-eluting stent implantation from the MATRIX registry. |
2012 |
Catheter Cardiovasc Interv |
pmid:22933349
|
Cassese S et al. |
Reduced antiplatelet therapy after drug-eluting stenting: multicenter Janus Flex carbostent implantation with short dual antiplatelet treatment for 2 or 6 months-MATRIX study. |
2012 |
Catheter Cardiovasc Interv |
pmid:21735531
|
Brillantes AB et al. |
Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. |
1994 |
Cell |
pmid:7514503
|
Jayachandran R et al. |
Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin. |
2007 |
Cell |
pmid:17632055
|
Sabatini DM et al. |
RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. |
1994 |
Cell |
pmid:7518356
|
Schreiber SL |
Immunophilin-sensitive protein phosphatase action in cell signaling pathways. |
1992 |
Cell |
pmid:1379518
|
Crabtree GR |
Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT. |
1999 |
Cell |
pmid:10089876
|
Goebl MG |
The peptidyl-prolyl isomerase, FK506-binding protein, is most likely the 12 kd endogenous inhibitor 2 of protein kinase C. |
1991 |
Cell |
pmid:1706222
|
Griffith JP et al. |
X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. |
1995 |
Cell |
pmid:7543369
|
Milan D et al. |
The latch region of calcineurin B is involved in both immunosuppressant-immunophilin complex docking and phosphatase activation. |
1994 |
Cell |
pmid:7525078
|
Chung J et al. |
Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. |
1992 |
Cell |
pmid:1377606
|
McKeon F |
When worlds collide: immunosuppressants meet protein phosphatases. |
1991 |
Cell |
pmid:1716181
|
Liu J et al. |
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. |
1991 |
Cell |
pmid:1715244
|
Cameron AM et al. |
Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux. |
1995 |
Cell |
pmid:8521476
|
Hemenway CS and Heitman J |
Calcineurin. Structure, function, and inhibition. |
1999 |
Cell Biochem. Biophys. |
pmid:10099825
|
Gu L et al. |
A retrospective study to compare the use of tacrolimus and cyclosporine in combination with adriamycin in post-transplant liver cancer patients. |
2015 |
Cell Biochem. Biophys. |
pmid:25287673
|
Rucha A and Verspohl EJ |
Heterologous desensitization of insulin secretion by GIP (glucose-dependent insulinotropic peptide) in INS-1 cells: the significance of Galphai2 and investigations on the mechanism involved. |
2005 May-Jun |
Cell Biochem. Funct. |
pmid:15376236
|
Gold BG |
Re: Jin E and Santo M "Neurite outgrowth of NG08-15 cells induced by heat shock protein 90 inhibitors". |
2008 |
Cell Biochem. Funct. |
pmid:18720425
|
Tang L et al. |
FK506 enhanced osteoblastic differentiation in mesenchymal cells. |
2002 |
Cell Biol. Int. |
pmid:11779223
|
Lee WS et al. |
Tacrolimus regulates endoplasmic reticulum stress-mediated osteoclastogenesis and inflammation: In vitro and collagen-induced arthritis mouse model. |
2018 |
Cell Biol. Int. |
pmid:28833755
|
Gabryel B and Bernacki J |
Effect of FK506 and cyclosporine A on the expression of BDNF, tyrosine kinase B and p75 neurotrophin receptors in astrocytes exposed to simulated ischemia in vitro. |
2009 |
Cell Biol. Int. |
pmid:19393753
|
PalacÃn M et al. |
FK506 affects mitochondrial protein synthesis and oxygen consumption in human cells. |
2013 |
Cell Biol. Toxicol. |
pmid:24077807
|
Takadera T et al. |
Cyclosporine A- and FK506-induced apoptosis in PC12 cells. |
2007 |
Cell Biol. Toxicol. |
pmid:17385075
|
MacMillan D et al. |
FK506-binding protein (FKBP12) regulates ryanodine receptor-evoked Ca2+ release in colonic but not aortic smooth muscle. |
2008 |
Cell Calcium |
pmid:17950843
|
Zheng YM et al. |
Role of FKBP12.6 in hypoxia- and norepinephrine-induced Ca2+ release and contraction in pulmonary artery myocytes. |
2004 |
Cell Calcium |
pmid:15036951
|
Bultynck G et al. |
Washing out of lipophilic compounds induces a transient increase in the passive Ca(2+) leak in permeabilized A7r5 cells. |
2002 |
Cell Calcium |
pmid:12098225
|
Bielefeldt K et al. |
Tacrolimus (FK506) modulates calcium release and contractility of intestinal smooth muscle. |
1997 |
Cell Calcium |
pmid:9502200
|
Zheng J et al. |
Ca(2+) release induced by cADP-ribose is mediated by FKBP12.6 proteins in mouse bladder smooth muscle. |
2010 |
Cell Calcium |
pmid:20451249
|
Tamareille S et al. |
High glucose-induced apoptosis through store-operated calcium entry and calcineurin in human umbilical vein endothelial cells. |
2006 |
Cell Calcium |
pmid:16243395
|
Reyes RC et al. |
Immunophilin deficiency augments Ca2+-dependent glutamate release from mouse cortical astrocytes. |
2011 |
Cell Calcium |
pmid:21163525
|
Avila G and Dirksen RT |
Rapamycin and FK506 reduce skeletal muscle voltage sensor expression and function. |
2005 |
Cell Calcium |
pmid:15955561
|
Gibon J et al. |
Store-depletion and hyperforin activate distinct types of Ca(2+)-conducting channels in cortical neurons. |
2010 |
Cell Calcium |
pmid:20621761
|
Turner JD et al. |
Calcineurin activation by slow calcium release from intracellular stores suppresses protein kinase C regulation of L-type calcium channels in L6 cells. |
2009 |
Cell Calcium |
pmid:19758695
|
Mayrleitner M et al. |
The calcium release channel of sarcoplasmic reticulum is modulated by FK-506 binding protein: effect of FKBP-12 on single channel activity of the skeletal muscle ryanodine receptor. |
1994 |
Cell Calcium |
pmid:7511990
|
Lombardi A et al. |
Impaired mitochondrial calcium uptake caused by tacrolimus underlies beta-cell failure. |
2017 |
Cell Commun. Signal |
pmid:29132395
|
Cheng S and Rodier F |
Manipulating senescence in health and disease: emerging tools. |
2015 |
Cell Cycle |
pmid:25928330
|
Werneck MB et al. |
Cyclosporin A inhibits colon cancer cell growth independently of the calcineurin pathway. |
2012 |
Cell Cycle |
pmid:22992618
|
Meller R et al. |
Seizure-like activity leads to the release of BAD from 14-3-3 protein and cell death in hippocampal neurons in vitro. |
2003 |
Cell Death Differ. |
pmid:12728252
|
Lim SW et al. |
Klotho enhances FoxO3-mediated manganese superoxide dismutase expression by negatively regulating PI3K/AKT pathway during tacrolimus-induced oxidative stress. |
2017 |
Cell Death Dis |
pmid:28771227
|
Que J et al. |
Effect of FK506 in reducing scar formation by inducing fibroblast apoptosis after sciatic nerve injury in rats. |
2013 |
Cell Death Dis |
pmid:23470533
|
Bassing CH et al. |
FKBP12 is not required for the modulation of transforming growth factor beta receptor I signaling activity in embryonic fibroblasts and thymocytes. |
1998 |
Cell Growth Differ. |
pmid:9543388
|
Barten MJ et al. |
Pharmacodynamics of T-cell function for monitoring immunosuppression. |
2007 |
Cell Prolif. |
pmid:17227295
|
Fujii H et al. |
Nonlinear decoding and asymmetric representation of neuronal input information by CaMKIIα and calcineurin. |
2013 |
Cell Rep |
pmid:23602566
|